Comparison of the GMA-TULIP and I-gel Laryngeal Mask for Airway Management in General Anaesthesia: a Randomized Controlled Trial
1 other identifier
interventional
198
1 country
1
Brief Summary
The goal of this clinical trial is to learn if GMA-TULIP laryngeal mask willfit well in the right place in participants undergoing trauma surgery in a supine position under general anaesthesia. It will also learn about the convenience, effectiveness and safety of the GMA-TULIP laryngeal mask. The main questions it aims to answer are: Does the GMA-TULIP laryngeal mask exhibit better anatomical alignment? Does the GMA-TULIP laryngeal mask perform effectively in trauma surgery patients in a supine position under general anaesthesia? Researchers will compare with the i-gel laryngeal mask (a device already popular among anaesthetists) to see if the GMA-TULIP laryngeal mask works to have a good performance in general anaesthesia. Participants will describe feelings immediately after anesthesia, 1 hour later and 24 hours later.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 5, 2025
CompletedFirst Posted
Study publicly available on registry
June 13, 2025
CompletedStudy Start
First participant enrolled
July 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 3, 2025
CompletedJune 13, 2025
March 1, 2025
5 months
June 5, 2025
June 5, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Accuracy of anatomical alignment under fiberoptic bronchoscopy observation
Class I: Vocal cords visible. Class II: Vocal cords and posterior epiglottis visible. Class III: Vocal cords and anterior epiglottis visible, \<50% visual obstruction of epiglottis to vocal cords. Class IV: Vocal cords and anterior epiglottis visible, \>50% visual obstruction of epiglottis to vocal cords. Class V: Vocal cords not visible. We define Class I and II field of view as accurate alignment; Class III and IV vision are defined as poor alignment; Class V vision is defined as alignment failure.
After insertion of laryngeal mask
Secondary Outcomes (13)
Number of laryngeal mask insertions
After anesthesia induction
Placement time of laryngeal mask
After anesthesia induction
Difficulty level of laryngeal mask insertion
After insertion of laryngeal mask
Time of insertion of gastric tube through laryngeal mask airway
After insertion of laryngeal mask
Number of gastric tube insertions
After insertion of laryngeal mask
- +8 more secondary outcomes
Study Arms (2)
G group
EXPERIMENTALParticipants who will use the GMA-TULIP laryngeal mask
I Group
ACTIVE COMPARATORParticipants who will use the i-gel laryngeal mask
Interventions
insert GMA-TULIP laryngeal masks after anesthesia induction
Eligibility Criteria
You may qualify if:
- years old ≤ age ≤ 70 years old. Patients undergoing trauma surgery in a supine position under general anesthesia.
- kg/m2 ≤ BMI ≤ 35 kg/m2. American Society of Anesthesiologists (ASA) grades I-III. Can understand the research process and the use of pain scales. Clear understanding and voluntary participation in the study, signing of informed consent form.
You may not qualify if:
- Patients with known or predicted difficult airways. High risk of reflux or aspiration (e.g., gastroesophageal reflux disease patients).
- Individuals with active upper respiratory tract infections. Cervical related diseases or surgical history. Preoperative sore throat or previous sore throat or hoarseness. Patients with oral and maxillofacial trauma or fractures. Other reasons why researchers believe it is not appropriate to participate in the experiment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Qilu Hospital of Shandong University
Jinan, Shandong, 250012, China
Study Officials
- STUDY CHAIR
Shaozhong Yang, Doctor
Qilu Hospital of Shandong University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 5, 2025
First Posted
June 13, 2025
Study Start
July 1, 2025
Primary Completion
December 1, 2025
Study Completion
December 3, 2025
Last Updated
June 13, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
After the research is completed, share research data, research plans, statistical analysis plans, informed consent forms, and other data